Powered by

PathAI and Gilead Show AI-Powered Pathology Research Models Accurately Interpret Liver Histology in Patients with NASH at AASLD 2019; Machine learning-based analyses of phase 3 trial provide quantitative assessments of liver histology and highlight hetero

Nov 08, 2019 - PR Newswire

PR Newswire

BOSTON, Nov. 8, 2019 /PRNewswire-PRWeb/ -- PathAI, a global provider of artificial intelligence (AI)-powered technology for use in pathology research, today announced the results of analyses examining the severity of nonalcoholic steatohepatitis (NASH) in liver biopsy samples from patients enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations were demonstrated between AI-powered and manual pathologist interpretations of the histological features of NASH. T...